Replies to post #718 on Oncternal Therapeutics Inc (ONCT)

[alx8967]

Good point. Thanks for the correction in my oversight. I personally prefer VKTX when it comes to the sarms trials because they seem to be severely undervalued. But GTXI does seem to have some of the bumps cleared up.